Company Description

Founded in Sweden in 2012, IRRAS is a commercial medical device company, focused on designing, developing, and commercializing innovative solutions that transform fluid management after surgical procedures. Our initial clinical focus is on intracranial procedures, where excess cerebrospinal fluid (CSF) often needs to be drained and intracranial pressure (ICP) needs to be closely regulated.

IRRAS’ first commercial product, IRRAflow®, is a next generation intracranial fluid exchange system that consists of a patented dual lumen catheter and control unit with proprietary software that work together to manage the drainage of excess fluid, intelligently manage the regulation of the patient’s ICP, and, on a regular basis, proactively flush the catheter to prevent occlusions from forming.

Year founded


Served area

Europe and USA


Vasagatan 16, 11120 Stockholm – Sweden

Filings & Publications


Report Q1 H1 Q3 FY
Consolidated Report SWE
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

Shareholder information

Shares outstanding



Jan. 1, 2000

Stock exchange(s)

Nasdaq Stockholm



Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.